These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25125496)

  • 21. Inhibition of LXRα-dependent steatosis and oxidative injury by liquiritigenin, a licorice flavonoid, as mediated with Nrf2 activation.
    Kim YW; Kim YM; Yang YM; Kay HY; Kim WD; Lee JW; Hwang SJ; Kim SG
    Antioxid Redox Signal; 2011 Mar; 14(5):733-45. PubMed ID: 20677908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
    Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
    Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. α-Terpineol induces fatty liver in mice mediated by the AMP-activated kinase and sterol response element binding protein pathway.
    Choi YJ; Sim WC; Choi HK; Lee SH; Lee BH
    Food Chem Toxicol; 2013 May; 55():129-36. PubMed ID: 23274539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
    Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
    Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
    Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
    Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
    Yang J; Craddock L; Hong S; Liu ZM
    J Cell Biochem; 2009 Feb; 106(3):414-26. PubMed ID: 19125418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cynandione A from Cynanchum wilfordii inhibits hepatic de novo lipogenesis by activating the LKB1/AMPK pathway in HepG2 cells.
    Kim S; Yoon YY; Park YW; Whang WK; Park SY; Hwang KW
    J Nat Med; 2020 Jan; 74(1):142-152. PubMed ID: 31463669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice.
    Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T
    Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
    Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
    J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnolia officinalis attenuates free fatty acid-induced lipogenesis via AMPK phosphorylation in hepatocytes.
    Seo MS; Hong SW; Yeon SH; Kim YM; Um KA; Kim JH; Kim HJ; Chang KC; Park SW
    J Ethnopharmacol; 2014 Nov; 157():140-8. PubMed ID: 25261688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.
    Li X; Hu X; Pan T; Dong L; Ding L; Wang Z; Song R; Wang X; Wang N; Zhang Y; Wang J; Yang B
    Biomed Pharmacother; 2021 Jan; 133():110802. PubMed ID: 33202286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis.
    Shearn CT; Smathers RL; Jiang H; Orlicky DJ; Maclean KN; Petersen DR
    J Nutr Biochem; 2013 Aug; 24(8):1436-45. PubMed ID: 23465594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oleanolic Acid Inhibits Liver X Receptor Alpha and Pregnane X Receptor to Attenuate Ligand-Induced Lipogenesis.
    Lin YN; Chang HY; Wang CCN; Chu FY; Shen HY; Chen CJ; Lim YP
    J Agric Food Chem; 2018 Oct; 66(42):10964-10976. PubMed ID: 30351048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes.
    Oh GS; Yoon J; Lee GG; Oh WK; Kim SW
    J Pharmacol Sci; 2015 Jun; 128(2):71-7. PubMed ID: 26109499
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.